Lupus Therapeutics Market
According to Intent Market Research, the Lupus Therapeutics Market is expected to grow from USD 5.7 Billion in 2024-e at a CAGR of 5.5% to touch USD 7.9 Billion by 2030. The Lupus Therapeutics Market is dominated by key players such as, GlaxoSmithKline plc, AstraZeneca plc, Roche Holding AG, Bristol Myers Squibb, Eli Lilly and Company, and Pfizer Inc.